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Functional	  Magnetic	  Resonance	  Imaging	  has	  been	  used	  for	  over	  a	  decade	  to	  
measure	  the	  effects	  of	  sugar	  on	  the	  hypothalamus,	  the	  appetite-­‐regulating	  center	  of	  the	  
brain.	  Hypothalamic	  activity	  decreases	  in	  a	  dose-­‐dependent	  manner	  in	  response	  to	  
glucose	  solution	  consumption.	  Fructose	  elicits	  an	  increase	  in	  hypothalamic	  activity.	  This	  
study	  aimed	  to	  understand	  the	  effects	  of	  high	  fructose	  corn	  syrup,	  a	  combination	  of	  
glucose	  and	  fructose	  on	  hypothalamic	  activity.	  Fasting	  blood	  samples	  were	  collected	  
from	  8	  (4M	  /4F)	  healthy	  adult	  volunteers	  who	  were	  then	  fed	  a	  standard	  breakfast	  and	  
transported	  to	  the	  Maryland	  Neuroimaging	  Center.	  Participants	  underwent	  two	  
successive	  scans.	  Prior	  to	  the	  first	  scan	  participants	  drank	  12	  oz.	  of	  either	  cola	  or	  water.	  
After	  the	  first	  scan	  participants	  received	  6	  oz.	  of	  either	  cola	  or	  water	  immediately	  prior	  
to	  the	  beginning	  of	  the	  second	  scan.	  	  Treatments	  were	  assigned	  in	  a	  Latin	  square	  
crossover	  design.	  Each	  scan	  included	  ~17mins	  of	  T2	  weighted	  functional	  scanning	  of	  
the	  hypothalamus	  (12	  mm	  mid-­‐sagittal	  slice;	  echo	  time:	  5ms;	  repetition	  time	  40ms;	  flip	  
angle:	  40°;	  FOV:	  210	  mm;	  in-­‐plane	  resolution:	  1.6mm	  X	  1.6mm).	  MANOVA	  revealed	  a	  	  
	  
	  
statistically	  significant	  three-­‐way	  interaction	  between	  time,	  volume	  and	  treatment	  
when	  	  the	  model	  was	  weighted	  with	  either	  fasting	  insulin	  (p<0.0001)	  or	  fasting	  
triglycerides	  (p=0.023).	  Gender	  also	  significantly	  interacted	  with	  time,	  volume	  and	  
treatment	  (p=0.008).	  Further,	  age	  was	  negatively	  correlated	  with	  overall	  average	  
hypothalamic	  signal	  intensity	  with	  volume	  as	  well	  with	  treatments.	  Both	  demographics	  
and	  metabolites	  strongly	  influence	  hypothalamic	  response,	  	  making	  it	  difficult	  to	  
determine	  the	  specific	  effects	  of	  high	  fructose	  corn	  syrup	  sweetened	  cola	  on	  appetite	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 The objective of this review is to introduce the reader to a new approach to the study of food 
intake and its control. Functional magnetic resonance imaging (fMRI) is now being used to study the 
neural mechanisms controlling hunger and appetite. Rather than attempt to summarize the entire field 
(that is growing exponentially) in what follows we hope to summarize a subset of that literature by 
focusing on the effects of sugars on brain activity as measured by fMRI.  We start this brief overview 
with an attempt to place this work in context.  The control of food intake has a long and rich history.  
Contemporary students of the neural controls of hunger and appetite recognize that multiple systems 
within the brain act in concert with one another to a common end.  Hypothalamic controls, hind brain 
integration of peripheral signals and taste/reward systems all contribute to our ability to monitor and 
control caloric intake.  
 The scientific study of the control of food intake has a history that spans the last 100 years. The 
pioneering works of C.P. Richter, Jean Mayer, Gordon Kennedy, Eliot Stellar, Jacques LeMagnen and 
dozens of others have all contributed to our understanding of the biological bases of hunger and satiety.  
Rather than attempt to review the entire area here, we offer the reader two excellent recent reviews that 
summarize contemporary hypotheses about hunger and satiety.  Guyenet and Schwartz5 and Choi6 have 
clearly outlined not only the role of the hypothalamus in the regulation of energy balance, but also noted 
that a segment of that region (specifically the ventromedial nucleus) plays several interactive roles in 
maintaining intake.  They also note that energy regulation results from an interaction not only of 
hypothalamic neurons, but includes input from brain reward as well as brainstem – sensory systems 
(Reviewed in 7).  
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We have chosen to focus on sugar solutions because of their relative simplicity from a nutrition 
perspective and because sweetened beverages constitute a major source of calories in the American diet. 
By studying the mechanisms involved with sugar solution intake we hope to develop a better 
understanding of how and why our usual appetite mechanisms fail to adequately protect us from 
overeating when we are presented with sweetened beverages.  Such an understanding could be 
instrumental in reversing the obesity epidemic facing the country.  
 
Obesity epidemic  
  
Recent statistics from the Center for Disease Control reveal that the obesity epidemic continues 
to spread throughout the US, with obesity rates in most states greater than 30% of adults.  Even more 
troubling is that in some segments of the American population an even greater percentage of people are 
affected.  For example more that 4 of 5 adult African American women are currently either overweight 
or obese. Perhaps most discouragingly of all the recent statistics is that no single factor, or combination 
of factors has been definitively identified as the cause or causes of the recent epidemic.  Failure in 
determining these root causes only leads to the persistence of the condition, and has resulted in the 
prediction that, for the first time, today’s US children will not be expected to live as long as their 
parents.   
 
Recent controversy about fructose and high fructose corn syrup 
Researchers have an ample number of hypotheses to consider guiding their efforts in determining 
the causes of obesity.  One such hypothesis is that the composition of the American diet has shifted from 
a diet low in sugars and high in complex  
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carbohydrates to one that is high in sugar.  Bray and colleagues1 have noted that the typical American 
now consumes 1000%+  more sugar than only one generation ago (Figure 1). Several lines of evidence 
have linked high sugar diets with insulin resistance and subsequent obesity and several researchers have 
identified specific sugars that are suspected of being effective in promoting obesity.  In particular, high 
fructose corn syrup has been linked to a myriad of metabolic changes conducive to promoting obesity.   
Effects of single nutrients on gene expression 
Mindful of these developments, we examined the short-term effects of sugar consumption on 
liver and adipose tissue 11β -hydroxysteroid dehydrogenase 1 (11β  HSD1) and glucose 6 phosphate 
dehydrogenase (G6PDH) message and expression 2.  These two enzymes have been linked to obesity 
(and in particular omental obesity) in both human and animal models. The question posed was: “Could 
any one sugar affect the regulation and/or expression of these enzymes?”  We reported that rats given 
24h access to dilute fructose solutions dramatically increased hepatic 11β HSD1 and G6PDH message 
and protein, whereas controls given access to the same concentration of glucose had no effect on either 
enzyme.  We went on to show that 7-day access to sucrose had a comparable effect on hepatic 11β  
HSD1.  Again, 7-day access to glucose failed to induce any significant effect on either enzyme, despite 
comparable sugar intake to either sucrose or fructose fed rats.  Clearly, different sugars could influence 
these critical components of sugar-induced obesity. 
 
Effect of fructose in particular 
More recently we repeated one of London et al.’s experiments by giving rats 24h access to one of 
4 different dilute sugar solutions in addition to unrestricted access to standard diet 3.  Hypothalamic 
samples taken from the brains of these animals were then probed using PCR arrays (BioScience Inc., 
Gaitherburg, MD).  Several differences in appetite-regulating genes between sugar fed and control rats 
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were noted, including a dramatic suppression in cholecystokinin that was specific to fructose-fed rats.  
Differences in gene expression could be attributed to several factors, such as over-eating, novelty, and 
differences in sensory and reward factors that accompany sugar intake. However fructose (and not high 
fructose corn syrup or any other sugar tested) promoted several unique changes in hypothalamic controls 
and was the only sugar tested that additionally produced a pronounced increase in circulating 
triglycerides. Although Storlien4  and others have reported that long-term exposure to fructose can 
induce hypertriglyceridemia, to our knowledge we were the first to demonstrate that this effect could be 
produced with as little as overnight access.  These studies provide convincing evidence that fructose is 
uniquely suited to promote both regulatory and metabolic conditions that cause obesity.  
 
Glucose affects hypothalamic signaling  
The main function of carbohydrate metabolism is to modulate postprandial blood glucose to 
avoid high or low glucose concentrations – both of which cause cellular damage. Postprandial 
carbohydrates, disaccharides and polysaccharides, are broken down by enzymes on intestinal villi into 
one unit sugars called monosaccharides. Glucose, a monosaccharide, is considered the physiologically 
preferred sugar for energy use and storage. From the intestine, glucose is absorbed into the blood stream.  
The brain uses about 25% of blood glucose as a primary fuel source. The glucose rich blood travels 
through the hepatic portal vein, which stimulates a biphasic insulin secretion from pancreatic beta cells 
proportionate to the concentration of blood glucose. Insulin then travels through the blood stream 
facilitating glucose uptake into cells for storage or energy use. Within the hypothalamus insulin can bind 
and inhibit the action of Neuropeptide-Y/ Agouti-related Protein (NPY/AGRP) neurons, known 
modulators of food intake. Additionally, glucose-sensing neurons of the hypothalamus are inhibited by a 
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rise in blood glucose. As a consequence, glucose ingestion and subsequent insulin secretion reduce 
neuronal activity within the hypothalamus. 
FMRI  
Functional Magnetic Resonance Imaging (fMRI) is a non-invasive method of measuring changes 
in the brain. Prior to the inception of functional imaging, MRI had been used almost exclusively for 
clinical imaging of abnormal or damaged tissues (Figure 2). True to its namesake, MRI uses magnetic 
resonance to image particular tissues when set to a particular frequency. A proton spins about itself on 
an axis but when a magnetic field is introduced that axis will align with the field. The alignment of the 
protons with the magnet creates a “resting” energy state, which can be disrupted by radiofrequencies. 
The application of the radiofrequency wave increases the energy state of the protons. When the 
radiofrequency wave is removed the protons return to their magnetic alignment, doing so releases 
energy frequencies, which are integrated through the radiofrequency coils to create an image. A series of 
multiple images that reveal moment-to-moment changes in the brain is called functional magnetic 
resonance imaging (fMRI). Blood oxygen level dependent (BOLD) fMRI takes measuring changes 
within the brain a step further. BOLD fMRI is based on the imaging property of blood in its oxygenated 
or deoxygenated state (Figure 3). When imaged at a particular frequency oxygenated blood appears 
almost black on a gray scale, while deoxygenated blood appears light gray. When a neuron becomes 
active oxygen is required; therefore, changes in blood flow occur to supply the neuron with oxygen. This 
translates into BOLD fMRI, which measures blood oxygenation levels within the brain to determine 
differences in neuronal activity.  
The development of BOLD fMRI technology has promoted its use in research. The most 
common application is to measure cognitive functions such as learning and memory. Imaging of the 
hypothalamus could reveal differences in substrate metabolism as well as demographic variations in 
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responsiveness to nutrient challenges. However, the location of the hypothalamus makes imaging 
challenging. The presence of a major sinus immediately adjacent to the hypothalamus makes imaging 
the region particularly difficult, as echoes from the empty sinus interfere with imaging. 
 
Applying fMRI to the study of the effects of sugars on the hypothalamus 
Using BOLD fMRI, a decrease in hypothalamic activity in response to both oral and intravenous 
glucose administration has been reported. Smeets8 observed oral consumption of a 25g or 75g glucose 
solution elicited a 1-2.5% signal decrease in the hypothalamus shortly after consumption. Furthermore, 
the 75g dose induced a greater reduction in hypothalamic activity compared to the 25g dose; the 75g 
dose was also significantly different from control for at least 5 minutes longer than the 25g dose. When 
analyzed regionally, only the upper anterior hypothalamus (UAH) and upper posterior hypothalamus 
(UPH) observed a reduction in signal due to glucose administration; only the upper anterior 
hypothalamus responded to glucose in a dose dependent manner. Smeets9 was able to repeat his previous 
results of a 1.5-2% hypothalamic signal decrease in response to a 75g glucose solution administered 
orally. When they compared oral and intravenous glucose administration, an equivalent glucose infusion 
resulted in a transient 1% hypothalamic signal decrease. Furthermore, the signal reduction extended 
from an onset time of 9 minutes to at least 20 minutes when glucose was administered orally versus an 
onset time of 4 minutes to 17 minutes for IV glucose administration.  The difference observed in 
magnitude is likely a result of GI regulatory mechanisms stimulated when glucose is orally 
administered.  Smeets8  sought to determine if hypothalamic signal decreases were a function of sweet 
taste or caloric density. A non-nutritive sweetened solution of aspartame was created with equal 
sweetness of a 75-g glucose solution in addition to an equicaloric solution of maltodextrin. Neither 
solution decreased hypothalamic activity nor did they differ from control. Regional analysis of the UPH 
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showed inconsistent but significant decreases in response to the maltodextrin solution. These results 
suggest that hypothalamic signal decrease is dependent on both calories and sweet taste. 
Extrahypothalamic signal changes also occur in response to glucose administration. Liu10 
analyzed the whole brain response after oral glucose administration. This study looked at clusters of 
activity change over a time period and noted two peaks in activity. The first peak was observed in the 
supplementary motor area, somatosensory cortex, cerebellum, anterior cingulate and orbitofrontal 
cortex. This peak is most likely the result of sensory and visceral signaling but is not considered a result 
of “eating” because control did not produce the same peak. The second peak of activity was observed as 
a decrease in signal within the hypothalamus around 7.7 – 12.8 minutes post ingestion. These results are 
consistent with previously discussed effects of glucose on hypothalamic activity and serves as validation 
for research in hypothalamic brain activity changes in response to sugar solutions. 
 
Changes in circulating glucose and circulating insulin levels in response to a glucose solution are 
believed to be the predominating factor for changes in hypothalamic activity when a glucose solution is 
consumed. However, several signaling pathways respond to the consumption of both glucose solutions 
or an equal volume of water. Matsuda11 was among the first to observe a decrease in hypothalamic 
activity in response to the water control. By using obese and lean subjects they sought to determine 
differences in hypothalamic signal changes in response to a glucose solution. To measure controls 8 of 
the 20 subjects were randomly chosen to consume an equal volume of water as the glucose treatment 
solution. When analyzed regionally the consumption of the water elicited a signal decrease in 
hypothalamic activity that was reportedly “virtually identical to that of glucose”. This result suggests 
that gastric motility may attenuate hypothalamic signals. It is important to note that this is the only study 
that observed a response to water consumption. 
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Increases in hypothalamic activity can be observed when subjects undergo hyperinsulinemic 
clamp sessions. Page12 demonstrated that a decrease in blood glucose results in a two-fold increase in 
hypothalamic activity dependent on counter regulatory hormones like glucagon, epinephrine and growth 
hormone. Subjects observed an increase in hypothalamic activity when plasma glucose was around 77.2 
+/- 2 mg/dL. Musen13 demonstrated that non-diabetic subjects had hypothalamic activation when blood 
glucose dropped to 68+/- 9mg/dL, the same results were seen in insulin dependent diabetic subjects at 
76+/- 8mg/dL. Note that these numbers are not significantly different. 
Specificity: Glucose vs. Fructose 
 Glucose is not the only monosaccharide that is metabolized by the body. Fructose is another 
monosaccharide that the body metabolizes -  but through an unregulated pathway. Almost all absorbed 
fructose upon entering the blood stream is quickly taken up by the liver. Fructose, unlike glucose, 
becomes metabolized to 2 glyceraldehyde-3-phosphate (G3P) molecules immediately with minimal 
regulatory mechanisms.  This is where the term “instant triose” originates. The metabolic processes that 
take place after this are highly debated. Many believe that the influx of G3Ps are eventually metabolized 
into Acetyl-CoA, which in turn increases de novo lipogenesis.  Others believe that fructose is simply 
incorporated in to the metabolic pathway of glucose. Page12 performed a study to determine if fructose 
could cross the blood brain barrier and be metabolized within the brain. Using rats, a 20% fructose 
infusion raised plasma fructose levels more than 20-fold.  As a result, Page observed an increase in the 
amount of fructose found in dialysis fluid taken from the ventral medial hypothalamic region. 
Additionally, GLUT5 and ketohexokinase mRNA was expressed in the hypothalamus, which indicates 
that fructose could be metabolized within the hypothalamus. These results suggest that fructose could be 
used as an energy source within the brain.  It is important to note that the fructose was infused and not 
orally administered, and in that way bypassed hepatic uptake of fructose. We are left to conclude that 
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fructose may be used in the brain as an energy source, but the amount of fructose that reaches the brain 
is likely negligible.  
Other appetite regulatory mechanisms can be altered differentially by glucose and fructose. For 
example, Page12 demonstrated that a fructose solution affects the hypothalamus differently than a 
glucose solution. Consistent with several other previously reported studies, they found a decrease in 
hypothalamic activity in response to the consumption of a glucose solution. They also reported that 15 
minutes after subjects consumed a glucose solution a reduction in hypothalamic cerebral blood flow of -
6.84 mL/g was observed.   Hypothalamic cerebral blood flow (CBF) increased 5.10 mL/g in response to 
an equal concentration fructose solution. An overall decrease in hypothalamic cerebral blood flow 
averaged -5.45 mL/g in response to a glucose solution and 2.84 mL/g in response to a fructose solution.  
Several other differences between glucose and fructose treatments were reported. Glucose 
administration increased plasma glucose, insulin and GLP-1 whereas fructose administration increased 
circulating lactate and PYY. There were no differences in circulating leptin or ghrelin between glucose 
and fructose treated subjects.  In an earlier study, Purnell14 attempted to find a difference between 
glucose and fructose when delivered intravenously. However, their results were inconclusive and 
showed fructose decreasing hypothalamic activity and glucose increasing hypothalamic activity in the 
control region. Smeets9 demonstrated that hypothalamic signal changes are difficult to measure when 
glucose is administered intravenously rather than orally. Additionally, the hypothalamus is difficult to 
image using fMRI technology due to size and placement.  
 The hypothalamus is not the sole regulator of appetite in the brain. There are many pathways the 
hypothalamus communicates with to respond to changes in appetite. Page12 measured the functional 
connectivity between the hypothalamus and the rest of the brain when subjects were given either a 
glucose or fructose solution. After glucose administration subjects’ functional connectivity increased in 
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the thalamus, caudate and putamen,whereas connectivity was only increased to the thalamus after 
fructose consumption. In addition to a reduction in CBF in the hypothalamus reductions were seen in the 
thalamus, insula, anterior cingulate and striatum after glucose consumption. In response to the 
consumption of the fructose solution CBF decreased in the thalamus, hippocampus, posterior cingulate 
cortex, fusiform gyrus, and visual cortex. The changes in activity observed when a glucose solution was 
administered are conducive to a satiety response for both homeostatic and reward centers. The response 
to fructose consumption suggests an inability to properly regulate appetite for both homeostatic and 
reward centers. 
 
I. Taste And Reward 
Reward Pathway The reward pathway is a brain circuit that plays a critical role in motivating 
reward-based learning, development of goal-directed behaviors, responses to food intake, and monetary 
rewards15-17.  This network is part of the cortico-basal ganglia that includes the prefrontal cortex (PFC), 
nucleus accumbens (NAcc), ventral tegmental area (VTA), and the medial dorsal nucleus (MD) of the 
thalamus15. The reward pathway uses dopamine (DA) as one of its main neurotransmitters to mediate 
signals in response to rewards18. This pathway also responds to drugs of abuse such as cocaine or 
heroin19. Recently sugar has been suggested to stimulate the reward pathway as well and possibly bring 
about sugar “addiction” or addiction related behaviors20,21.  
Gustatory (Taste) Pathway The gustatory (taste) pathway involves signals that originate from taste 
receptors in the mouth and throat22. The five main taste sensations are sweet, salty, bitter, sour, and 
umami23. These signals travel to the brain via nerves, including the chorda tympani and 
glossopharyngeal nerves, through the nucleus of the solitary tract in the medulla, the thalamus and 
primary taste cortex to the amygdala and hypothalamus22,24. The taste pathway is important in 
discriminating not only taste but also post-ingestive consequences regarding caloric content to the 
12	  
	  
brain25. Additionally, sweet and bitter taste receptors  (T1R and T2R respectively) have been identified 
in the gastrointestinal tract (GI) indicating taste signals are not limited to the mouth and throat 
region26,27. Taste perception can be disrupted in obese people resulting in positive reward system 
activation in response to any, not just palatable, taste cues28.  Furthermore, artificial sweeteners can also 
play a role in disrupting the natural homeostatic taste mechanisms responsible for regulating taste and 
food ingestion29.  
Reward and Calorie Content  
Two of the recurring questions asked by researchers over the years have been “How does the 
reward value of a food item relate to its calorie content?” and “What is the connection between a reward 
received and the ability of the brain to discern its caloric content?”  In a study focusing on the caloric 
content of food, Killgore30 and associates reported that amygdalar activation as measured by fMRI was 
high following presentation of food pictures when compared to non-food pictures. High-calorie foods 
produced increased activation of the hypothalamus and frontal cortex areas30, thereby contributing to the 
brain’s ability to evaluate the reward value of higher-calorie foods.  
This natural mechanism can be complicated with the use of artificial sweeteners such as 
saccharin, a non-nutritive sweetener. Green29 has reported that there are differences in brain activity 
between subjects who commonly consume diet soda when compared to subjects who regularly consume 
soda sweetened with caloric sweeteners. In diet soda drinkers, there was a large response in the 
dopaminergic midbrain as measured by fMRI when consuming either saccharin or sucrose29. These 
results indicate the reward system has modified itself within the diet soda drinker to respond to both 
caloric and non-caloric sweet taste, and does not discriminate based on caloric content. Green speculated 
that this change may in fact lead to changes in body weight as a person may not be able to evaluate 
caloric content and may overeat. These findings are consistent with those of Davidson and Swithers31 
13	  
	  
who reported that rats given intermittent sweet taste and calories were unable to compensate for a sweet 
and caloric pre-meal compared to rats given consistent sweet taste and calories. While rats are much 
better at tightly regulating their caloric intake, there may still be similar changes seen in human 
populations.  
Rudenga32 has reported that fMRI-measured activation of the amygdala was affected differently 
between people who drink artificially sweetened drinks and those who drink sugar-sweetened beverages. 
They reported that there was a negative correlation in people who regularly used artificial sweetener and 
their amygdala response to sucrose. The amygdala has been shown to be involved in flavor-nutrient 
conditioning, which allows for preference of flavor previously paired with sucrose over saline33. 
Reduced amygdalar activation as measured by fMRI resulted from treatment with a µ-opioid receptor 
inverse agonist in subjects consuming palatable food34. As already noted above, disruptions in flavor 
sensing and the ability to judge caloric content have the potential to impact regulation of caloric intake. 
 
Taste and Reward in Obese vs. Non-Obese 
 The brain activity of obese people is significantly different from that of normal weight controls. 
Some of these differences include the reward pathway. In an fMRI study, people with high body mass 
index measurements showed activation in their reward pathway in response to high-calorie taste cues35. 
Furthermore, the people showing high reward pathway activity also had a greater number of binge-
eating symptoms. These two observations make it tempting to suspect that reward pathway activation 
links reward processing with binge eating35.  In another fMRI study, obese subjects had high levels of 
activation in the NAcc for all samples that provided a taste (sweet, fatty, or quinone) whereas controls 
varied their response depending on taste cues28. This study suggests the obese subjects did not 
discriminate among tastes, but rather discriminated against the lack of taste. Leptin deficient obese 
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subjects treated with leptin had lower activation in the striatum in response to food images36. 
Additionally, in obese women there is wide spread activation of the reward system in response to high-
calorie food pictures37. These results indicated that changes might occur within the reward system either 
as a result of or as a correlate to obesity, which represses the natural taste and reward systems.  
 
Obesity and Type II Diabetes 
 Obesity and type II diabetes are polygenic diseases for which a cause is still unknown. However, 
type II diabetes is often preceded by obesity though a genetic component which can be exacerbated by 
environmental factors.  One environmental factor is diet and as previously mentioned sugar intake has 
been shown to be a potential contributor to these diseases. Obesity in general is the inability of the body 
to properly maintain energy homeostasis. Matsuda11 sought to determine any differences in 
hypothalamic activity in response to a glucose solution between lean and obese subjects. They observed 
an attenuated and delayed response in the obese group. Both groups still experienced a decrease in 
hypothalamic activity but the obese group decreased by 4.8% whereas the lean group decreased by 
7.9%. Additionally, obese subjects did not observe a significant reduction in hypothalamic activity until 
9.4 minutes post ingestion whereas the lean group responded sooner,  at 6.4 minutes post ingestion. This 
delay was observed in two different regions of the hypothalamus, the lateral posterior hypothalamus 
(LPH) as well as the UAH.  Plasma glucose concentrations were not different between groups during the 
fMRI session. However, fasting plasma insulin and mean plasma insulin were significantly higher in this 
same obese group. Additionally, fasting plasma leptin was 21 µg/L higher in the obese group versus the 
lean group.  
 Smeets9 compared hypothalamic activity in response to consumption of an oral glucose solution 
between type 2 diabetic subjects and healthy controls. The control group observed a reduction in 
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hypothalamic activity congruent with previous studies. By contrast, the type II diabetic group’s BOLD 
signal in any hypothalamic area remained unaffected.  Additionally, when the type II diabetic group 
consumed water the hypothalamic activity was increased significantly in the lateral anterior 
hypothalamus (LAH) and LPH. These results suggest that subjects with type II diabetes may lack a 
regulatory mechanism required for energy homeostasis within the hypothalamus. The results do not give 
any indication as to what regulatory mechanism is missing and whether this response contributed to or 
was caused by the type II diabetes.  
 
Conclusions 
 Functional magnetic resonance imaging is providing new perspectives into how the brain 
controls food intake and energy metabolism.  This review offers only a limited insight into the extent to 
which this new technology is contributing to a better understanding of how and why we eat what we eat.  
Here we have focused on the effects of sugars on brain regions that are known to participate in hunger 
and appetite.  The early reports of this work make it clear that sugar affects several neural systems that 
can be monitored by fMRI.  Hypothalamic, sensory and reward pathways are all influenced by sugar.  It 
remains to be determined how different sugars influence the activities of each pathway.  Early evidence 
supports the speculation that not all sugars act alike.  The application of this technology also serves to 
test in humans hypotheses about regulatory mechanisms that originated in animal models. For example, 
can the suppressive effect of fructose on hypothalamic cholecystokinin be observed using fMRI?  Future 
applications of this technology will undoubtedly advance our understanding of these effects and in that 













Chapter 2:Appetite Signals in the Brain: High Fructose Corn Syrup Sweetened 












Contemporary students of the neural controls of hunger and appetite recognize that multiple 
systems within the brain act in concert with one another to a common end. Guyenet and Schwartz5 and 
Choi6 have clearly outlined not only the role of the hypothalamus in the regulation of energy balance, 
but also noted that a segment of that region (specifically the ventromedial nucleus) plays several 
interactive roles in maintaining intake.  
Recent statistics from the Center for Disease Control reveal that the obesity epidemic continues 
to spread throughout the US, with obesity rates in most states greater than 30% of adults.  Even more 
troubling is that in some segments of the American population an even greater percentage of people are 
affected.  For example, more that 4 of 5 adult African American women are currently either overweight 
or obese. Perhaps most discouragingly of all the recent statistics is that no single factor, or combination 
of factors has been definitively identified as the cause or causes of the recent epidemic. 
Sweetened beverages constitute a major source of calories in the American diet. Bray and 
colleagues1 have noted that the typical American now consumes significantly more sugar than only one 
generation ago. Several lines of evidence have linked high sugar diets with insulin resistance and 
subsequent obesity and several researchers have identified specific sugars that are suspected of being 
effective in promoting obesity.  In particular, high fructose corn syrup has been linked to a myriad of 
metabolic changes conducive to promoting obesity.  Rats given 24h access to one of 4 different dilute 
sugar solutions in addition to unrestricted access to standard diet showed several differences in appetite-
regulating genes between sugar fed and control rats when hypothalamic tissue was sampled 3.  
A series of multiple images that reveal moment-to-moment changes in the brain is called 
functional magnetic resonance imaging (fMRI). Blood oxygen level dependent (BOLD) fMRI takes 
measuring changes within the brain a step further. BOLD fMRI is based on the imaging property of 
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blood in its oxygenated or deoxygenated state. When a neuron becomes active oxygen is required; as a 
consequence changes in blood flow occur to supply the neuron with oxygenate blood. This translates 
into BOLD fMRI, which measures blood oxygenation levels within the brain to determine differences in 
neuronal activity.  
FMRI is an excellent non-invasive method for imaging the hypothalamus, although the location 
of the hypothalamus makes imaging challenging. The presence of a major sinus immediately adjacent to 
the hypothalamus makes imaging the region particularly difficult, as echoes from the empty sinus 
interfere with imaging.  Several researchers have successfully imaged the hypothalamus. Smeets8, 
observed oral consumption of a 25g or 75g glucose solution elicited a 1-2.5% signal decrease in the 
hypothalamus shortly after consumption. Furthermore, the 75g dose induced a greater reduction in 
hypothalamic activity compared to the 25g dose; the 75g dose was also significantly different from 
control for at least 5 minutes longer than the 25g dose. Smeets9 also demonstrated that glucose infusion 
does not decrease hypothalamic activity to the same magnitude as oral glucose, thus  the change in 
hypothalamic activity is only partially attributed to blood glucose concentration. When Page12 compared 
glucose to fructose, hypothalamic response to both solutions was quite different. Fructose increased 
hypothalamic activity while glucose decreased hypothalamic activity by the same magnitude from 
baseline. Fructose is taken up by the liver after digestion, leaving almost none available to travel to the 
brain. Therefore, the effects of fructose are most likely a secondary response to fructose metabolism. 
Americans are consuming a combination of glucose and fructose rather than one or the other, which 
makes these results poorly suited to identify possible mechanisms in obesity.  
This study aims to identify the effects of high fructose corn syrup on hypothalamic activity via 
cola. High fructose corn syrup (HFCS) comes in many glucose to fructose ratios. The most common is 
45:55 glucose to fructose. Given the opposing affects of glucose and fructose, hypothalamic activity 
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could remain unchanged when administered simultaneously. However, glucose acts directly on the brain 
in conjunction with insulin, whereas fructose does not. Therefore, we predict hypothalamic response will 
reflect the affects of the glucose rather than the opposing of both sugars By studying the mechanisms 
involved with sugar solution intake we hope to develop a better understanding of how and why our usual 
appetite mechanisms fail to adequately protect us from overeating when we are presented with 
sweetened beverages. 
 
Materials and Methods 
 
Subjects 
Eight healthy adult men (n=4) and women (n=4), between 25 and 70 years of age with a body mass 
index (BMI) between 19 and 38 kg/m2, were recruited from the Baltimore-Washington area. Participants 
were screened at the Beltsville Human Nutrition Research Center (BHNRC).   Eligibility criteria 
included: participants were non-smokers; free of active cardiovascular disease, diabetes, and metabolic 
or malabsorption syndromes; and were not taking lipid-lowering medications. In addition, participants 
were required to have blood pressure ≤ 180/100 mm Hg, fasting triacylglycerol ≤ 300 mg/dl and fasting 
glucose ≤ 126 mg/dl. Written informed consent was obtained from all subjects.  This study’s protocol 
was approved by University of Maryland’s Institutional Review Board. 
 
Experimental Procedure 
Each testing day participants came into the BHNRC, following a 12-hour overnight fast. After a fasted 
blood draw each participant was fed a standardized breakfast meal. The standardized test meal consisted 
of a breakfast sandwich (English muffin, egg, sausage, cheese) and a hash brown (Table 1). Participants 
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were required to refrain from consuming caffeine, as well as any other foods or beverages prior to 
testing.  
 
Blood Sampling and Processing 
Serum and plasma samples were collected at each blood draw. Plasma samples were gently inverted and 
placed on ice. Blood collected for serum was gently inverted and held at room temperature for 30 
minutes after collection prior to centrifugation. Plasma and serum samples were portioned into 
cryogenic vials and stored at -80ο C for subsequent analyses. 
 
Plasma and Serum Assays 
Plasma insulin concentrations were measured by ELISA (LINCOplex; LINCO Research). 
Triacylglycerol (TG) and glucose (GLU) were both measured using an automated clinical chemistry 
analyzer (Vitros 5,1 FS) (Orthoclinical Diagnostics, Rochester, NY). TG were measured in serum and 
GLU was measured in sodium fluoride/EDTA plasma using colorimetric/rate microslide technology.  
 
fMRI Scanning 
Following breakfast, participants proceeded to the University of Maryland Neuroimaging Center 
(MNC). Participants underwent magnetic resonance imaging in a 3T Siemens MAGNETOM Trio 
scanner. Each subject was positioned supine on the patient table, equipped with ear plugs and 
headphones to reduce noise. Participants were then allowed to sit up and consume 12 oz. of treatment 1. 
No time requirement was given, but participants were urged to consume their treatment quickly but not 
too fast as to cause discomfort. Participants were then returned to the supine position, where a Siemens 
12 channel head matrix coil was placed over the participant’s head. Foam cushions were supplied 
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between the head coil and the head to reduce movement. Functional scans began promptly using 
conventional gradient echo sequence (T2-weighted) to scan a 12 mm midsagittal slice, manually 
positioned to capture the hypothalamus  (TR= 40 ms, TE=5, flip angle=40º, FOV of 210 mm,  FOV 
phase 100%, Phase resolution 100%, In-plane resolution of 1.6×1.6 mm). The functional imaging run 
took approximately ~17 minutes during which a total of consecutive 50 scans were performed. Upon 
completion of the functional scans, the participant was removed from scanner and allowed to take short 
break (~5 min) if desired. Scanning procedures were then repeated with the participant receiving 6 oz. of 
treatment 2. Upon completion of the second functional run, a T1-weighted anatomical scan (Sagittal 
MPRAGE, TR=1900ms, TE=2.52ms, flip angle 9°, FOV=250 mm, resolution= 1.0 x 1.0 x 1.0 mm, 176 
slices with 18.2% slice oversampling) was taken.   
 
Beverage testing 
To measure the effects of Coca-Cola on the hypothalamus, subjects reported to the MNC on 4 testing 
days, separated by no less than a week. Each testing day participants underwent two successive imaging 
sessions. The experimental condition prior to the first session was either 12oz of Coca-Cola or 12oz of 
bottled water. Upon completion of the first session participants received either 6oz of Coca-Cola or 6oz 
of bottled water immediately prior to the beginning of the second scan.  Treatments were assigned in a 




For each imaging session, the T1-weighted MPRAGE image was used to manually trace the region-of-
interest (ROI) of the hypothalamus on the middle sagittal plane of the data. The 50 functional images 
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were processed in a consecutive order, and then an image registration program 
(http://afni.nimh.nih.gov/afni/) was used to correct the head motions in a 2-dimentional setting, and 
aligned the functional images with the MPRAGE image in the middle sagittal plane.  The hypothalamus 
functional signal at each time point was then estimated by averaging the image intensities of all the 
pixels within the hypothalamus ROI in the aligned functional data. 
 
Data Analysis 
Average signal intensity of the region of interest (ROI), which traced the hypothalamus, were obtained 
from each slice and then entered into a spreadsheet. Overall average signal intensity is the average of all 
50 average signal intensities. The signal intensities of the ROI were used for statistical analyses. 
Analysis of Co-Variance (ANACOVA) adjusted for repeated measures was used to test for effects of 
treatment and volume over the 17 minutes of functional scanning. Adjustments for the effect of 
metabolic factors like fasting triglycerides were weighted in ANACOVA analyses. Correlational 





All of the subjects who began the study were able to complete the entire study (Table 2). The original 
scanning parameters, which imaged two functional slices, did not produce a reliable signal from the 
hypothalamus. Therefore, the scanning parameters were changed and all scans using the original 
scanning parameter could not be used. The data used for analysis is missing 6 imaging sessions of the 32 
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in total. Of the 6 imaging sessions that were lost, the first two imaging sessions for subjects 1 and 2 as 
well as the first imaging session for subjects 3 and 4 were lost.  
 
Hypothalamic activity responds to dose 
Fifty functional slices were obtained during the 17-minute functional imaging session. Therefore, the 
average signal intensity within the hypothalamus was recorded 50 times approximately 17 minutes post 
ingestion. Preliminary analyses revealed that volume is most likely affecting the hypothalamus, perhaps 
via stomach distension or fullness signals sent from the vagus nerve to the hypothalamus (Figure 4). 
Multivariate analysis revealed no significant effect of volume or treatment in hypothalamic signal 
intensity. However, the signal intensities are significantly affected by time (p=0.005). When the signal 
intensities across the 50 time points are fitted with a line, there is a slight positive slope. These results 
suggests dose, the combination of treatment and volume, does affect neuronal activity in the 
hypothalamus but differential effects of the treatments (Cola and water) and volumes (12oz and 6oz) 
were not found. In previous studies, the hypothalamus has been shown to respond to treatment rapidly 
then slowly return to baseline activity. Because there is a delay between delivering the treatment and the 
initiation of the functional scanning, the initial response to treatment may have been missed. The slope 
of the response can infer the return to baseline. The first imaging session, 12oz treatment, had no 
statistically significant effect on the second imaging session, 6oz treatment. Therefore, subjects’ 
hypothalamic activity was returned to baseline before the second treatment was administered. It is also 
important to note that there was no effect of the testing day. Subjects underwent the entire experimental 
procedure over 4 separate testing days; which could theoretically alter response due to variables like 
anticipation. However, the order of treatment was structured in a Latin square design to help counter any 
of these possible effects. It is important to note that the effect of the testing day was calculated using 
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subjects 5-8 because some data was lost for subjects 1-4. Therefore, only subjects 5-8 completed a Latin 
square.   
 
Insulin and Triglycerides Affect Hypothalamic Response 
Further multivariate analyses that adjusted the model for fasting insulin revealed a strong significant 
three-way interaction between time, volume and treatment (p<0.0001). Furthermore, including fasting 
triglycerides data, but not fasting glucose data, produced a significant three-way interaction between 
time, volume and treatment (p=0.023 and p=0.23 respectively). These results suggest that circulating 
triglycerides and circulating insulin in some way influence hypothalamic responses. Insulin binds to 
many neurons within the hypothalamus as a modulator of intake including NPY/AGRP neurons. 
Triglycerides are metabolized into free fatty acids, which might indirectly modulate hypothalamic 
activity by regulating leptin activity. Glucose acts on the glucose sensing neurons of the hypothalamus. 
However, the exact function of these neurons has not been determined. The locations of these neurons 
are most dense in the lateral hypothalamus.  Unfortunately the lateral hypothalamus may be poorly 
represented due to scanning limitations. 
Correlational analyses were used to further analyze the relationship between hypothalamic 
response and circulating metabolites. Hypothalamic response as measured by overall average 
hypothalamic signal intensity is positively correlated with fasting triglycerides as well as fasting insulin 
but not fasting glucose (Table 3). Higher fasting triglycerides and insulin were associated with higher 
hypothalamic signal intensity, thus the hypothalamus was less responsive to treatment. High fasting 
triglycerides and insulin are indicators of metabolic dysfunction, thus hypothalamic response is partially 
inhibited by errors of metabolism. As previously demonstrated by Matsuda11, hypothalamic responses to 
a glucose solution are blunted in obese subjects when compared with lean controls. These results support 
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previous reports of a relationship between metabolic dysfunction and decreased responsiveness in the 
hypothalamus11. Interestingly, Body Mass Index (BMI) does not correlate with hypothalamic signal 
intensity. This result may be due to BMI’s inability to reliably measure metabolic dysfunction. While a 
BMI greater than 30 is the definition of obesity, BMI is a ratio of height-to-weight but does not reliably 
measure body composition or unhealthy fat depots like abdominal obesity which are better indicators of 
metabolic dysfunction.  
 
Age and Gender predict hypothalamic response 
 Demographics such as age and gender appear to impact hypothalamic response to treatment. When 
gender is included into the mixed effects model, a significant 4-way interaction between gender, time, 
volume and treatment is revealed (Figure 5). Men and women are inherently different metabolically due 
to differences in body composition. Therefore, the same dose given to a woman would potentially be 
diluted metabolically by the increase in lean body mass and total body mass in men. Age was negatively 
correlated to the hypothalamic signal response to both treatment and volume (Table 4). These results 
indicate that as an individual ages their hypothalamus is either more responsive to dose or their baseline 
hypothalamic activity is lower. BOLD fMRI is dependent on blood flow and the ability to oxygenate 
blood, which the normal degradation of these systems could result in lower baseline activity. Without 
baseline data it is difficult to determine the most likely cause of decreased hypothalamic response with 
age (Figure 6). 
 
Discussion 
Appetitive and metabolic signals from various systems are received and processed in the 
hypothalamus. The hypothalamus then sends its own signals to various systems in the periphery to 
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orchestrate metabolic processes. Therefore, the hypothalamus is the center for appetite and metabolism. 
Dysfunction of this regulatory system results in the inability to properly regulate body weight, caloric 
intake as well as other metabolic processes. These data demonstrate the ability to elicit change in 
hypothalamic activity by administering sugar solutions of different volumes. However, differential 
effects of high fructose corn syrup sweetened cola compared to water were not evident. One factor that 
may have hindered our ability to observe statistically significant effects of treatment could be a lack of 
statistical power. Factors, such as cost, limited the size of the sample population. Furthermore, these data 
show that the sensitivity of hypothalamic responsiveness is dependent on circulating metabolites like 
insulin and triglycerides but not glucose. Other factors that influence metabolism such as age and gender 
were also strong predictors of hypothalamic response. Clearly, metabolic status influences how the brain 
responds and reacts to HFCS-sweetened cola. 
 Our results show the hypothalamus responded to both treatments of cola and water. Matsuda11 
has reported hypothalamic response to water.  He reported that the response to water was identical to the 
glucose response but only within a segmented region of the hypothalamus, as opposed to the entire 
hypothalamic area. Others observed no change from baseline8,12. However, all previous reports are based 
on fasted subjects whereas our study fed all subjects a standardized meal. It may be that stomach 
distention was a greater influence in this study. The effect of being fed rather than fasted could be 
partially responsible for why differences were not evident between cola and water. Fasting and feeding 
are both methods used to ensure subjects are on similar metabolic planes and will respond similarly. 
Other studies used fasted subjects which may have lead the hypothalamus to be hyper responsive to the 
sugar solutions8-12. Conversely, our subjects may have been less responsive to our treatment because 
their systems had recently been metabolizing the standardized meal. In the case of measuring the effects 
of high fructose corn syrup, hypothalamic response may be minimized due to the opposing effects of 
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fructose and glucose. Therefore, hypothalamic response to high fructose corn syrup may be best 
measured in fasted subjects, who are likely to more responsive to treatment.  
 The influence of metabolites like insulin and triglycerides on hypothalamic activity has been 
implicated in previous studies8,12. High levels of insulin and triglycerides are often indicative of the 
body’s inability to properly metabolize substrate. These errors of metabolism were apparent in our 
subjects’ reduced hypothalamic responses when fasting triglycerides or fasting insulin were elevated. 
Previous research has shown the hypothalamus of obese subjects is less responsive to a glucose solution 
compared to that of lean subjects. Interestingly, plasma insulin was higher in obese subjects but plasma 
glucose was the same between obese and lean.  
 Aging is the slowing and breakdown of metabolic processes, which often leads to lower basal 
activity. Our data shows lower hypothalamic activity in older subjects; a response most likely due to the 
result of lower baseline activity. An alternative hypothesis would be that the hypothalamus is hyper 
reactive with increasing age due to an inability to finely modulate response. Apart from age biases, our 
results showed differential responses between men and women. Apart from differences in body 
composition, the hypothalamus is sexually dimorphic. For example, the estrogen receptors are 
differentially expressed in neuron between men and women.  Previous studies have not reported age or 
gender biases in hypothalamic responses. However, previously reported sample populations were not 
appropriately diverse to determine age or gender effects9,12.   
Understanding the impact of hypothalamic response on obesity will continue to be studied using 
fMRI. While the method is not perfected and the use of the scanner is expensive, the benefits of 
observing time-lapsed responses in the human brain are invaluable. Future studies on hypothalamic 
response to sugar solutions should focus on finding new parameters for measuring hypothalamic 
activity. Single slice fMRI imaging is not ideal, partly because motion correction software cannot 
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process the 2D slices without the entire brain in 3D slices. The current method of imaging will be 
sufficient for measuring simple hypothalamic responses but analysis of extra-hypothalamic interactions, 
like reward pathways, are extremely limited in two dimensions.  
The hypothalamus processes many peripheral signals.   Here we demonstrated the impact of 
triglycerides and insulin on hypothalamic response. Other peripheral systems like the GI and liver have 
long known interactions with the hypothalamus. Studying these systems in conjunction with 
hypothalamic response would help with further understanding of where obesity originates. For example, 
how does the modern diet impact liver metabolism and does that impact then dampen hypothalamic 
responses? The effect of other nutrients, such as fat, on hypothalamic response would be the next logical 
nutrient given the extensive effects of fat on the HPA axis.  
Our immediate next steps are to two fold. We must first focus on the effects of high fructose corn 
syrup on hypothalamic activity using baseline measurements and increasing our number of treatments to 
include glucose, fructose and sucrose. Because caffeine is a vasoconstrictor and is present in many types 
of cola, the effect of caffeine on hypothalamic response and fMRI imaging must be delineated. 
Furthermore, increasing the sample sizes would be beneficial to not only analysis of hypothalamic 
response to treatment but to the co-variables noted in this study, like age. Common sample sizes in fMRI 
research are at least 30 subjects due to the variability in functional imaging. Additionally, a larger 
sample size that includes a wider range in the age of adults would allow the impact of age to be better 
defined.  
The hypothalamus is a dense region of appetite and metabolic processing. Hypothalamic 
dysfunction has been shown to impact health and obesity. Understanding the many intricate systems 
within the hypothalamus will enable researchers to add another piece to the puzzle of obesity in the 



































Figure	  1.	  Fructose	  Consumption	  1961-­‐2000.	  Graphical	  representation	  of	  estimated	  total	  fructose	  
(•),	  free	  fructose	  (▴),	  and	  high-­‐fructose	  corn	  syrup	  (HFCS,	  ♦)	  intake	  in	  relation	  to	  increasing	  
prevalence	  of	  overweight	  (▪)	  and	  obesity	  (x)	  in	  the	  United	  States	  from	  1961	  -­‐	  2000.	  Adapted	  from	  













Figure	  2.	  FMRI	  3-­‐Tesla	  Magnet.	  Image	  of	  the	  fMRI	  3-­‐Tesla	  Magnet	  used	  at	  the	  University	  of	  



















Figure	  3.	  BOLD	  Signal.	  	  When	  blood	  hemoglobin	  is	  oxygenated	  it	  contains	  no	  unpaired	  electrons	  
and	  thus	  is	  not	  attracted	  to	  a	  magnetic	  field.	  	  However	  it	  becomes	  paramagnetic	  (has	  unpaired	  
electrons)	  when	  deoxygenated.	  This	  difference	  in	  magnetic	  properties	  makes	  it	  possible	  to	  detect	  
small	  differences	  in	  the	  MR	  signal	  of	  blood.	  Thus,	  the	  changes	  in	  oxygenation	  reflect	  levels	  of	  
neural	  activity.	  This	  form	  of	  MRI	  is	  known	  as	  blood	  oxygenation	  level	  dependent	  (BOLD)	  imaging.	  
Adapted	  from	  	  Huettel,	  S.,	  Song,	  A.,	  &	  McCarthy,	  G.	  (2009).	  Functional	  magnetic	  resonance	  imaging.	  















Figure 4. Dose Response in Hypothalamus. Illustrated above is the average hypothalamic signal 
intensity at each of the 50 time points, separated by dose (Treatment and Volume). These data show 
differential response of the hypothalamus to volume, hypothalamic activity appears to be lower when 
either 12oz treatment is administered compared to the 6oz treatments. Differential effects of Coke vs. 



































































































Figure 5. Four-Way Interaction Gender*Time*Treatment*Volume. Illustrated above is the average 
hypothalamic signal intensity across each of the 50 time points separated by gender and dose. (Red 
data=Women, Blue data=Men) These data show differences in response to dose, dependent on gender. 
The women’s responses were relatively constant and showed greater differentiation to dose. The men’s 
responses were sporadic and show almost no differentiation to volume or treatment. It is important to 


















































Figure 6. Increased Age Associated with Increased Hypothalamic Response. Illustrated above are the 
overall average hypothalamic signal intensity compared to age. These data show a significant negative 
correlation between increased age and decreased hypothalamic activity when data is separated by 












































































Weight (g) 193  
Calories (kcal) 460  
Total fat (g)  27 
Saturated fat (g) 8 
Trans fat (g)  0 
Protein (g)  15 
Carbohydrate (g)  41 
Dietary fiber (g) 3 
Sodium (mg) 1100 
Potassium (mg) 170 
Cholesterol (mg) 125 
 
Table 1. Nutrient Analysis of Standardized Breakfast. This table shows the nutrient profile of the 
standardized breakfast the subjects were fed the morning of each imaging session after the fasted blood 
draw. Nutrient analysis was calculated using The Food Processor: Version 10.11.0 (ESHA Research, 












 Women    n=4 
Data are means ± SEM 
Men     n=4 
Data are means ± SEM 
 Mean Mean 
Age (years) 55.3 ± 4.8 55.8 ± 2.6 




















































Table 3. Fasting Metabolites are Predictive of Hypothalamic Response. This table shows the correlation 
between overall average hypothalamic signal intensity and each of the three fasting metabolites, 













Table 3. Metabolite Correlations 




Coefficient P- value 
Volume 
12 oz. 
Triglyceride 0.567 0.003 
Insulin 0.518 0.007 
Glucose -0.160 0.435 
6 oz. 
Triglyceride 0.575 0.002 
Insulin 0.445 0.023 
Glucose -0.039 0.851 
Treatment 
Cola 
Triglyceride 0.577 0.002 
Insulin 0.468 0.014 
Glucose -0.133 0.507 
Water 
Triglyceride 0.555 0.004 
Insulin 0.503 0.010 









Table 4. Hypothalamic Response Increases with Age. This table shows the negative correlation between 
overall average hypothalamic signal intensity and age. Older subjects had the lowest hypothalamic 

























Table 4. Age Correlations 
    
Correlation 
Coefficient P-value 
Volume 12oz -0.552 0.003 
6oz -0.423 0.032 
Treatment Cola -0.522 0.005 
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